EmeraMed is funding a Phase II clinical trial on using NBMI to treat mercury toxicity in gold miners located in Colombia, SA that will take at least 3 months to complete. Hopefully, this study will suffice for FDA approval for marketing authority in the USA. <…>. We are also hopeful that the INVIMA officials will approve NBMI for use in S. American countries after successful completion of our Phsse II study. We have anecdotal results in the USA that NBMI will reduce urinary Hg levels by over 90% with our Phase II treatment with 600 mg NBMI per day.
🙏